| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/21/2009 | US7521535 Anti-microbial defensin-related peptides and methods of use |
| 04/21/2009 | US7521533 Tryptase polypeptide and uses thereof |
| 04/21/2009 | US7521532 Comprises nucleotide sequences coding transmembrane protein for diagnosis and treatment immunological and autoimmune diseases |
| 04/21/2009 | US7521529 Lantibiotics; biosynthesis; solid phase synthesis; deblocking, deprotecting |
| 04/21/2009 | US7521528 Point mutations; for treating conditions characterized by decreases in bone mass such as osteoporosis |
| 04/21/2009 | US7521527 Glucagon-like peptide-1 (GLP-1); for treatment of diabetes, obesity, excessive appetite, insufficient satiety, and metabolic disorders; for converting liver stem/progenitor cells into functional pancreatic cells |
| 04/21/2009 | US7521477 Vitamin C derivatives with peptide, preparation method thereof and composition comprising the same |
| 04/21/2009 | US7521426 Peptides and DNA encoding peptides that carry novel cytotoxic T lymphocyte epitopes derived from fragments of human immunodeficiency virus-1 Pol or envelope proteins and carry HLA-A*1101 binding motif; vaccines |
| 04/21/2009 | US7521424 Albumin fusion proteins |
| 04/21/2009 | US7521423 Exendin pharmaceutical compositions |
| 04/21/2009 | US7521422 Use of aspartic proteases in cosmetics and therapeutics |
| 04/21/2009 | US7521419 Peptide-based compounds |
| 04/21/2009 | US7521417 Method and apparatus for preparing an acellular red blood cell substitute |
| 04/21/2009 | US7521258 Methods of detecting, measuring, and evaluating modulators of body weight in biological samples, and diagnostic, monitoring, and therapeutic uses thereof |
| 04/21/2009 | US7521241 Regulated gene expression in plants |
| 04/21/2009 | US7521240 Chromosome-based platforms |
| 04/21/2009 | US7521235 Unique novel Bacillus thuringiensis gene with Lepidopteran activity |
| 04/21/2009 | US7521233 Providing to endothelial cells cultured on a porous matrix or scaffold that supports tissue growth in vitro an amount of an osteoprotegerin |
| 04/21/2009 | US7521229 replication-defective recombinant adenovirus comprising a heterologous nucleic acid sequence encoding an antigenic determinant of Plasmodium falciparum; ntigenic determinant comprises an immunogenic peptide of the circumsporozoite protein; viral vectors |
| 04/21/2009 | US7521228 Spider silk protein encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
| 04/21/2009 | US7521215 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 04/21/2009 | US7521211 exhibiting improved activity relative to the native insulin-like growth factor 1 and II polypeptide; The fusion component F is selected from the group consisting of a human IgG constant region, Fc domain, and heavy chain; muscle atrophy |
| 04/21/2009 | US7521208 Human cytokine receptor designated as Zcytor14 polypeptide; antiinflammatory agent |
| 04/21/2009 | US7521205 Genes and polypeptides relating to prostate cancers |
| 04/21/2009 | US7521204 Bacillus host cell |
| 04/21/2009 | US7521202 Generating soluble human leukocyte antigens in cells from genomic DNA or cDNA, for prevention of viral, bacterial and proliferative disorders; polymerase chain reaction |
| 04/21/2009 | US7521197 Method for producing cytotoxic T-cells |
| 04/21/2009 | US7521193 Human diabetes-mediating proteins |
| 04/21/2009 | US7521192 EDG: modulators of lymphocyte activation and migration |
| 04/21/2009 | US7521188 Optical monitoring of cleaving enzyme activity |
| 04/21/2009 | US7521177 Contacting the sample with a flavivirus antigen,produced by expressing a transcriptional unit encoding a Japanese encephalitis virus (JEV) signal sequence and an immunogenic flavivirus antigen of a flavivirus; detecting an increase in antigen/antibody complex formation |
| 04/21/2009 | US7521175 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571 |
| 04/21/2009 | US7521060 Pathogen for bacterial poultry disease |
| 04/21/2009 | US7521058 Nucleotide sequences coding viral protein for use in vaccinations and veterinary medicine |
| 04/21/2009 | US7521056 Fusion propteins; homogeneous purity, and unaltered affinity, and can be produced in high yields without the requirement of extensive purification; stable in serum to allow in vivo applications |
| 04/21/2009 | US7521055 Detecting variant allele of human ferroportin1 gene and evaluating DNA sequence; administering inhibitor of Ferroportin1 iron transport function; oxidative damage in mammals, iron deficiency, hemochromatosis, anemia, and blood disorders; replication; administering polypeptide, immune response |
| 04/21/2009 | US7521054 Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the Fv to lower the isoelectric point |
| 04/21/2009 | US7521049 Administering fusion proteins, immunoglobulins, and multimeric proteins; pharmacokinetics; age-related macular degeneration and diabetic retinopathy |
| 04/21/2009 | US7521046 Antibody immunization therapy for treatment of atherosclerosis |
| 04/21/2009 | US7521044 Human histone deacetylase, HDAC9c |
| 04/21/2009 | US7521043 Gene therapy for tumors using minus-strand RNA viral vectors encoding immunostimulatory cytokines |
| 04/21/2009 | US7520929 Gluten proteins intermolecularly covalently linked through polythiol compounds such as trimethylolpropane tri(3-mercaptopropionate); improved fracture toughness, impact properties, for use in biodegradable composite materials, coating fibers, foams |
| 04/21/2009 | CA2399378C Sodium-independent small neutral amino acid transporters transporting l- and d-amino acids and genes thereof |
| 04/21/2009 | CA2398469C Antibody for detecting mycoplasma pneumoniae |
| 04/21/2009 | CA2378537C Chlamysin b antibacterial protein, gene encoding it and an expression system for it |
| 04/21/2009 | CA2362518C Heat-inducible promoter |
| 04/21/2009 | CA2289122C Bak promoter expression system |
| 04/21/2009 | CA2265976C High level expression of proteins |
| 04/21/2009 | CA2260022C Diagnosis of williams syndrome and williams syndrome cognitive profile by analysis of a lim-kinase gene |
| 04/21/2009 | CA2231603C Chicken interleukin-15 and uses thereof |
| 04/21/2009 | CA2193641C 66 kda antigen from borrelia |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/21/2009 | CA2115927C Peptides for inducing cytotoxic t-lymphocyte responses to hepatitis b virus |
| 04/21/2009 | CA1341594C Synthetic peptides and mixtures therof for detecting hiv antibodies |
| 04/16/2009 | WO2009049318A2 Freeze-dried plasma formats for the trauma care field |
| 04/16/2009 | WO2009049222A1 Compositions and methods of using the human proislet peptide receptor |
| 04/16/2009 | WO2009048961A1 Trimeric il-1ra |
| 04/16/2009 | WO2009048903A1 11 beta hydroxysteroid dehydrogenase type 1 |
| 04/16/2009 | WO2009048658A2 Optimized dengue virus entry inhibitory peptide (dn81) |
| 04/16/2009 | WO2009048538A2 Use of anti-amyloid beta antibody in ocular diseases |
| 04/16/2009 | WO2009048488A1 Glucoamylase variants with altered properties |
| 04/16/2009 | WO2009048487A1 Glucoamylase variants |
| 04/16/2009 | WO2009048133A1 Mite antigenic rice |
| 04/16/2009 | WO2009048071A1 Method and nucleic acid for detection of canine nkt cell |
| 04/16/2009 | WO2009048067A1 Genetically engineered blood coagulation factor x having no sugar chain, and method for production thereof |
| 04/16/2009 | WO2009047525A1 Methods of controlling plant seed and organ size |
| 04/16/2009 | WO2009047513A2 Antagonists of kisspeptin and uses thereof |
| 04/16/2009 | WO2009047301A1 Method for the recombinant production of magnetic nanoparticles |
| 04/16/2009 | WO2009047295A1 Assay for monitoring activity of frizzled receptors |
| 04/16/2009 | WO2009047241A1 Process for producing mature recombinant mite group i allergen |
| 04/16/2009 | WO2009047009A1 Fusion polypeptide comprising s-antigen repeat units |
| 04/16/2009 | WO2009046983A1 Soluble fragments of influenza virus pb2 protein capable of binding rna-cap |
| 04/16/2009 | WO2009046742A1 Staphylokinase variant |
| 04/16/2009 | WO2009046541A1 MODULATION OF SIRPα - CD47 INTERACTION FOR INCREASING HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT AND COMPOUNDS THEREFOR |
| 04/16/2009 | WO2009046535A1 Methods for assaying mc1r variants and mitochondrial markers in skin samples |
| 04/16/2009 | WO2009046520A1 A fusion tag comprising an affinity tag and an ef-hand motif containing polypeptide and methods of use thereof |
| 04/16/2009 | WO2009026334A3 Treatment with kallikrein inhibitors |
| 04/16/2009 | WO2009026151A3 Process for producing zein articles with limited solubility |
| 04/16/2009 | WO2009018667A8 Plant bioreactor for the production of interleukin-24 cytokine |
| 04/16/2009 | WO2009018219A3 Methods and compositions for modulating rad51 and homologous recombination |
| 04/16/2009 | WO2009014702A3 Cd74 for use in the treatment of cancer and liver toxicity |
| 04/16/2009 | WO2008156677A3 Cyclic peptide melanocortin receptor ligands |
| 04/16/2009 | WO2008150023A3 Method for producing antagonist of growth factor |
| 04/16/2009 | WO2008137881A9 Ehrlichia ewingii proteins, nucleic acids, and methods of their use |
| 04/16/2009 | WO2008117069A3 Cellulose binding domains and uses thereof |
| 04/16/2009 | WO2008070672A3 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 04/16/2009 | WO2008055916A9 New antigens for paratuberculosis diagnosis and vaccination |
| 04/16/2009 | WO2008049583A3 Process for selectively localizing active ingredients on and in mitochondria and corresponding active ingredients |
| 04/16/2009 | WO2008048680A3 Notch 2 signaling as a breast cancer suppressor pathway |
| 04/16/2009 | WO2008039483A9 Modified self-assembling peptides |
| 04/16/2009 | WO2008036717A3 Use of soluble galectin-3 (gal-3) for cancer treatment |
| 04/16/2009 | WO2007094985A3 Long-acting polypeptides and methods of producing and administering same |
| 04/16/2009 | WO2007052154A3 Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators |
| 04/16/2009 | WO2007044083A3 Evolved interferon-alpha polypeptides |
| 04/16/2009 | WO2007021733A3 Methods and compositions for enhancing protein folding |
| 04/16/2009 | WO2007016606A3 Compositions and methods for modulating rank activities |
| 04/16/2009 | WO2007015918A3 Novel biologically active peptides and their new uses |
| 04/16/2009 | WO2007005559A3 Tat-005 and methods of assessing and treating cancer |
| 04/16/2009 | WO2006130769A3 Methods for treatment of growth disorders |
| 04/16/2009 | WO2006127655A3 Enhancement of hydroxy fatty acid accumulation in oilseed plants |